CompletedNot Applicable

Efficacy and Safety of Melatonin and Clonazepam for IRBD

South Korea34 participantsStarted 2017-11-09

Plain-language summary

This study aimed to evaluate influence of melatonin or clonazepam treatment on symptom and polysomnographic parameters in patients with idiopathic REM sleep behavior disorder.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * REM sleep behavior disorder (ICSD-3 criteria) Exclusion Criteria: * Neurological disorder including epilepsy or stroke * History of psychiatric illness * Neurodegenerative disease including dementia or parkinsonism. * Medication affecting sleep within 1 month * Intake of melatonin or clonazepam within 1 week. * Unable to complete questionnaires

What they're measuring

Automated REM without atonia index

Timeframe: 4 weeks of prolonged release melatonin 2mg or clonazepam 0.5mg

Trial details

NCT IDNCT03255642

SponsorKyung Hee University Hospital at Gangdong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-01

View on ClinicalTrials.gov More REM Sleep Behavior Disorder trials